Bibliography
- Fahmy R , DanielsonD, MartinezM. Formulation and design of veterinary tablets. In: Pharmaceutical Dosage Forms: Tablets (3rd Edition). Augsburger LL, Hoag SW (Eds). Informa Healthcare Inc., NY, USA, 383–431 (2008).
- Martinez M , AmidonG, ClarkeL, JonesWW, MitraA, RiviereJ. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.Adv. Drug Deliv. Rev.54(6), 825–850 (2002).
- Martinez MN , PapichMG. Factors influencing the gastric residence of dosage forms in dogs.J. Pharm. Sci.98(3), 844–860 (2009).
- Rathbone MJ , MartinezMN. Modified release drug delivery in veterinary medicine.Drug Discov. Today7(15), 823–829 (2002).
- Lu DL , KowalskiTJ, Jarecki-BlackJ. Intellectual property issues for veterinary pharmaceuticals in the USA.Future Med. Chem.3(7), 847–850 (2011).
- Riviere JE . The future of veterinary therapeutics: a glimpse towards 2030.Vet. J.174(3), 462–471 (2007).
- Hunter RP , ShryockTR, CoxBR, ButlerRM, HammelmanJE. Overview of the animal health drug development and registration process: an industry perspective.Future Med. Chem.3(7), 881–886 (2011).
- Schofield J . Animal-health pharmaceuticals: research responsibilities and efforts in target animal safety and laboratory animal welfare.Future Med. Chem.3(7), 851–854 (2011).
- Martinez M , AntonovicL. Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?Future Med. Chem.3(7), 855–879 (2011).
Website
- Dog genome resources. www.ncbi.nlm.nih.gov/genome/guide/dog/ (Accessed 24February2011)